rs7521023

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001232.4(CASQ2):​c.*482C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.616 in 413,770 control chromosomes in the GnomAD database, including 79,849 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.64 ( 31288 hom., cov: 32)
Exomes 𝑓: 0.60 ( 48561 hom. )

Consequence

CASQ2
NM_001232.4 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.56

Publications

8 publications found
Variant links:
Genes affected
CASQ2 (HGNC:1513): (calsequestrin 2) The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family. Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells. The protein is a calcium binding protein that stores calcium for muscle function. Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest. [provided by RefSeq, Jul 2008]
CASQ2 Gene-Disease associations (from GenCC):
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Genomics England PanelApp
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 1-115700759-G-A is Benign according to our data. Variant chr1-115700759-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 292122.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.711 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASQ2NM_001232.4 linkc.*482C>T 3_prime_UTR_variant Exon 11 of 11 ENST00000261448.6 NP_001223.2 O14958-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASQ2ENST00000261448.6 linkc.*482C>T 3_prime_UTR_variant Exon 11 of 11 1 NM_001232.4 ENSP00000261448.5 O14958-1

Frequencies

GnomAD3 genomes
AF:
0.637
AC:
96777
AN:
151924
Hom.:
31250
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.718
Gnomad AMI
AF:
0.641
Gnomad AMR
AF:
0.677
Gnomad ASJ
AF:
0.547
Gnomad EAS
AF:
0.708
Gnomad SAS
AF:
0.643
Gnomad FIN
AF:
0.631
Gnomad MID
AF:
0.633
Gnomad NFE
AF:
0.579
Gnomad OTH
AF:
0.644
GnomAD4 exome
AF:
0.604
AC:
158029
AN:
261728
Hom.:
48561
Cov.:
0
AF XY:
0.602
AC XY:
79887
AN XY:
132728
show subpopulations
African (AFR)
AF:
0.716
AC:
5923
AN:
8272
American (AMR)
AF:
0.710
AC:
7175
AN:
10102
Ashkenazi Jewish (ASJ)
AF:
0.541
AC:
5075
AN:
9384
East Asian (EAS)
AF:
0.717
AC:
16596
AN:
23148
South Asian (SAS)
AF:
0.634
AC:
4931
AN:
7778
European-Finnish (FIN)
AF:
0.609
AC:
11218
AN:
18426
Middle Eastern (MID)
AF:
0.640
AC:
852
AN:
1332
European-Non Finnish (NFE)
AF:
0.576
AC:
95757
AN:
166290
Other (OTH)
AF:
0.618
AC:
10502
AN:
16996
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2858
5715
8573
11430
14288
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
542
1084
1626
2168
2710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.637
AC:
96873
AN:
152042
Hom.:
31288
Cov.:
32
AF XY:
0.642
AC XY:
47707
AN XY:
74284
show subpopulations
African (AFR)
AF:
0.718
AC:
29752
AN:
41454
American (AMR)
AF:
0.677
AC:
10341
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.547
AC:
1898
AN:
3470
East Asian (EAS)
AF:
0.707
AC:
3642
AN:
5152
South Asian (SAS)
AF:
0.645
AC:
3112
AN:
4824
European-Finnish (FIN)
AF:
0.631
AC:
6673
AN:
10580
Middle Eastern (MID)
AF:
0.636
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
0.579
AC:
39325
AN:
67974
Other (OTH)
AF:
0.642
AC:
1358
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1777
3553
5330
7106
8883
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.600
Hom.:
118320
Bravo
AF:
0.646
Asia WGS
AF:
0.684
AC:
2381
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Catecholaminergic polymorphic ventricular tachycardia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Catecholaminergic polymorphic ventricular tachycardia 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Caudal regression sequence Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Neural tube defect Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.32
DANN
Benign
0.37
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7521023; hg19: chr1-116243380; API